Product Information
IRBESARTAN 300 MG TABLET is a generic product labeled by Hisun Pharmaceuticals USA Inc., priced at $0.1530 per EA under NDC 42658012304. Its NADAC has been published 357 times since Aug 28, 2019.
Strength
300 mg/1
Manufacturer
Hisun Pharmaceuticals USA Inc.NDC
42658012304
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA206194On Market Since
4/15/2017
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 300 MG TABLET has been published 357 times since Aug 28, 2019, and over the history we have for it it has declined 51.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1530 per EA |
|---|---|
| All-time high | $0.3794 (Jun 10, 2020) |
| All-time low | $0.1461 (Feb 18, 2026) |
| 52-week high | $0.1799 |
| 52-week low | $0.1461 |
| Median price | $0.2434 |
| Average price | $0.2508 |
| Largest weekly change | +33.1% (Aug 21, 2024) |
| Weeks tracked | 357 |
| Tracking since | Aug 28, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 300 MG TABLET, manufactured by Hisun Pharmaceuticals USA Inc., is $0.1530 per EA (NDC 42658012304), effective Jun 24, 2026.
How has the price of IRBESARTAN 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 300 MG TABLET has declined 51.2%. It has been tracked across 357 weekly CMS publications since Aug 28, 2019.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 300 MG TABLET?
Since Aug 28, 2019, the NADAC for IRBESARTAN 300 MG TABLET has ranged from a low of $0.1461 (Feb 18, 2026) to a high of $0.3794 (Jun 10, 2020), with a median of $0.2434 per EA.
Are there cheaper alternatives to IRBESARTAN 300 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as IRBESARTAN 300 MG TABLET, but none are currently priced below it.
Who manufactures IRBESARTAN 300 MG TABLET?
IRBESARTAN 300 MG TABLET (NDC 42658012304) is labeled by Hisun Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification